Drug
Luveris
Luveris is a pharmaceutical drug with 5 clinical trials. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_1
1
20%
Ph phase_4
1
20%
Ph phase_2
1
20%
Ph phase_3
2
40%
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
Terminated1
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)
Phase 41 (20.0%)
Trials by Status
terminated120%
unknown120%
not_yet_recruiting120%
completed240%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruitingphase_3
FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients
NCT06227949
completedphase_1
Pergoveris FD and Liquid China BE Study
NCT04899193
terminatedphase_3
A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique
NCT01497197
completedphase_4
Synchronization of Follicle Wave Emergence and Ovarian Stimulation
NCT00439829
unknownphase_2
To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation
NCT01029470
Clinical Trials (5)
Showing 5 of 5 trials
NCT06227949Phase 3
FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients
NCT04899193Phase 1
Pergoveris FD and Liquid China BE Study
NCT01497197Phase 3
A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique
NCT00439829Phase 4
Synchronization of Follicle Wave Emergence and Ovarian Stimulation
NCT01029470Phase 2
To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5